Commonwealth Equity Services, LLC Galapagos Nv Transaction History

Commonwealth Equity Services, LLC

  • $66 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024
BUY
$31.87 - $40.71 $15,935 - $20,355
500 Added 8.33%
6,500 $264,000
Q3 2023

Oct 23, 2023
BUY
$34.17 - $42.98 $17,085 - $21,490
500 Added 9.09%
6,000 $207,000
Q2 2023

Aug 10, 2023
BUY
$37.4 - $44.52 $205,700 - $244,860
5,500 New
5,500 $224,000

Others Institutions Holding GLPG

# of Institutions
85
Shares Held
12.3M
Call Options Held
69.1K
Put Options Held
42.7K
View Full List

About GALAPAGOS NV

GLPG Quotes by TradingView
  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.9B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email